Martin Hojman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Martin hojman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Martin Hojman Today - Breaking & Trending Today

Roundup: Chinese COVID-19 vaccines effective against infection, mortality, say experts - China News


2021-07-30 07:35:30 GMT2021-07-30 15:35:30(Beijing Time) Xinhua English
BUENOS AIRES, July 30 (Xinhua) Experts in viral diseases and infectology have highlighted the efficacy of Chinese vaccines against COVID-19 and its new variants.
According to the evidence available so far, vaccines that have been licensed by the World Health Organization (WHO) are effective against all variants in circulation globally, Jairo Mendez Rico, adviser on emerging viral diseases to the Pan American Health Organization (PAHO), told Xinhua recently.
The WHO gave emergency-use approval to the COVID-19 vaccines developed by Chinese companies Sinopharm and Sinovac in May and June respectively.
We need to highlight the notable impact that vaccination has had in reducing mortality, severe cases and hospitalizations, which are fundamental objectives for controlling the epidemic, said the PAHO adviser. ....

United States , Buenos Aires , Distrito Federal , Martin Hojman , Carla Vizzotti , Cansino Biologics , Argentina Ministry Of Health , Pan American Health Organization , World Health Organization , Mendez Rico , National Vaccination Campaign , Reducing Mortality , Health Minister Carla Vizzotti , South American , ஒன்றுபட்டது மாநிலங்களில் , புஏனோஸ் ஐரிஸ் , திஸ்திரிதோ கூட்டாட்சியின் , கேன்சினோ உயிரியல் , அர்ஜெண்டினா அமைச்சகம் ஆஃப் ஆரோக்கியம் , பான் அமெரிக்கன் ஆரோக்கியம் ஆர்கநைஸேஶந் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , தேசிய தடுப்பூசி பிரச்சாரம் , குறைத்தல் இறப்பு , தெற்கு அமெரிக்கன் ,

Chinese COVID-19 vaccines effective against infection, mortality, say experts


Experts in viral diseases and infectology have highlighted the efficacy of Chinese vaccines against COVID-19 and its new variants.
According to the evidence available so far, vaccines that have been licensed by the World Health Organization (WHO) are effective against all variants in circulation globally, Jairo Mendez Rico, adviser on emerging viral diseases to the Pan American Health Organization (PAHO), told Xinhua recently.
The WHO gave emergency-use approval to the COVID-19 vaccines developed by Chinese companies Sinopharm and Sinovac in May and June respectively.
We need to highlight the notable impact that vaccination has had in reducing mortality, severe cases and hospitalizations, which are fundamental objectives for controlling the epidemic, said the PAHO adviser. ....

United States , Martin Hojman , Carla Vizzotti , Cansino Biologics , Argentina Ministry Of Health , Pan American Health Organization , World Health Organization , Battle Against Novel , Mendez Rico , National Vaccination Campaign , Reducing Mortality , Health Minister Carla Vizzotti , South American , ஒன்றுபட்டது மாநிலங்களில் , கேன்சினோ உயிரியல் , அர்ஜெண்டினா அமைச்சகம் ஆஃப் ஆரோக்கியம் , பான் அமெரிக்கன் ஆரோக்கியம் ஆர்கநைஸேஶந் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , போர் எதிராக நாவல் , தேசிய தடுப்பூசி பிரச்சாரம் , குறைத்தல் இறப்பு , தெற்கு அமெரிக்கன் ,

Argentina finds China's Sinopharm Covid-19 vaccine 84% effective in preventing death


BUENOS AIRES (XINHUA) - The Covid-19 vaccine developed by Chinese pharmaceutical company Sinopharm is 84 per cent effective in preventing death from the disease, according to a report by the Argentine Ministry of Health.
The document, titled Study of the National Vaccination Campaign s Effectiveness in Reducing Mortality from Covid-19 in People aged 60 and over, was prepared by the ministry with cases from the country s 24 provinces during the period from Jan 1 to June 22.
The study found that the Sinopharm vaccine has an efficacy of 84 per cent after the application of its two doses , state news agency Telam reported on Saturday (July 10).
The effectiveness against Covid-19 mortality in the Sinopharm vaccine reached 61.6 per cent with the application of the first dose in the 147,908 cases analysed, and increased to 84 per cent after the second dose was applied to the same number of people. ....

United States , Martin Hojman , Carla Vizzotti , Argentine Ministry Of Health , Argentine Society Of Infectious Diseases , Argentine Ministry , National Vaccination Campaign , Reducing Mortality , Health Minister Carla Vizzotti , South American , Argentine Society , ஒன்றுபட்டது மாநிலங்களில் , ஆர்கெண்டைன் அமைச்சகம் ஆஃப் ஆரோக்கியம் , ஆர்கெண்டைன் சமூகம் ஆஃப் தொற்று நோய்கள் , ஆர்கெண்டைன் அமைச்சகம் , தேசிய தடுப்பூசி பிரச்சாரம் , குறைத்தல் இறப்பு , தெற்கு அமெரிக்கன் , ஆர்கெண்டைன் சமூகம் ,